Venotonics for heavy legs

Venotonics are widely used drugs for heavy legs; But the Haute Autorité de Santé judged their medical serviceto be insufficient in 2001, and they were completely de-reimbursed in 2008. They relieve symptoms — but they don't treat venous disease. Here's what it means for you.

What is a venotonic?

The word venotonic — sometimes referred to as venotropes in medical records — refers to the same family of drugs. The two terms are synonymous and interchangeable.

To understand what they are for, one image is enough. In your legs, blood must flow back to the heart against gravity. The veins are equipped with small valves (valves) that prevent blood from flowing back. When these valves become damaged or the walls of the veins lose their tone, the blood has a hard time coming back up — it stagnates, and that's what causes the feeling of heavy legs, the swelling of the ankles, the tingling.

The purpose of venotonics is to strengthen the walls of the veins and reduce the small leaks of fluid that cause swelling. In practice, they reduce the discomfort felt — the heaviness, the pain, the impatience at bedtime. They are therefore symptomatic comfort medications.

Why are venotropes no longer reimbursed?

In France, venotonics have been massively prescribed for decades — among the most prescribed classes of drugs in general practice. Then, in 2008, the Health Insurance stopped reimbursing them. Why?
The answer can be found in the opinions published by the HAS Transparency Commission between 2001 and 2006. This has classified venotonics as a drug with insufficient Medical Service Rendered (SMR)1. This judgment does not mean that the drug is dangerous — it means that its clinical benefit, compared to the available alternatives, is insufficient to justify reimbursement.2

Do they have any adverse effects to be aware of?

Venotonics are generally well tolerated. The adverse effects reported are most often minor and temporary:

  • Digestive disorders (nausea, abdominal pain, diarrhoea) – the most common

Some precautions deserve special attention:

  • Most venotonics are not recommended during pregnancy and breastfeeding, especially in the first trimester, due to a lack of sufficient safety data.
  • In case of prolonged use (more than a few weeks), a medical consultation is recommended to ensure that the symptoms do not mask a progressive form of the disease.

What it means for you: the essential distinction

Acknowledging that the SMR is insufficient is not the same as saying that venotonics are useless. It's more nuanced.

They relieve symptoms 

Several controlled studies show that certain molecules in this family are superior to placebo on certain symptoms: reduction in the feeling of heavy legs, reduction in discomfort at bedtime, slight reduction in ankle swelling.3,4 This benefit exists, is perceived by patients, and may justify short-term use to relieve functional discomfort.

They do not alter the course of the disease5

This is the crucial point that the leaflets do not write in large print: no study has shown that venotonics slow the progression of chronic venous insufficiency — the formation of new varicose veins, the worsening of swelling, the progression to a venous ulcer. Treatment is symptomatic (it acts on the symptoms), not a modifier of the disease (it does not act on the cause).

What your doctor does with this information

In concrete terms, if you experience recurring heavy legs, the real question is not "which venotonic to buy?" But "do I have chronic venous insufficiency, at what stage, and what is the right treatment for me?" This diagnosis and decision-making is up to your GP, or a vascular doctor if the symptoms are marked.

⚠  Consult quickly if you observe:

  • Pain in one calf + redness + local warmth → suspicion of phlebitis (deep vein thrombosis)
  • Sudden swelling that appears quickly on one leg
  • Sores or ulcers on the legs that do not heal
  • Rapid worsening of symptoms within a few days

These situations are not self-medication — they require immediate medical attention.

Frequently asked questions

  • No. Dereimbursement does not mean dangerousness. It means that the clinical benefit is considered insufficient compared to the available alternatives to justify collective funding4. These drugs remain authorized for sale (they have an MA — Marketing Authorization), available in pharmacies, and can provide real relief in some patients.

  • For occasional and mild discomfort, yes — with the usual precautions: read the leaflet, tell the pharmacist about your other medications, do not take them if you are pregnant or breastfeeding. For chronic or recurrent symptoms, a medical consultation is preferable: heavy legs may indicate progressive venous insufficiency that deserves a check-up.

  • Because dereimbursement does not remove the authorization of prescription. A doctor may legitimately believe that a venotonic will improve your comfort of life in the short term — this is an individualized clinical decision, different from a public health recommendation.

  • Pregnancy is one of the most common times when heavy legs are most common — hormones relax the vein walls and the uterus gradually compresses the veins in the pelvis. Some venotonics can be used during pregnancy, it is advisable to refer to the leaflet and ask your doctor or pharmacist for advice.

    In this case, the HAS and the phlebology societies recommend non-drug measures: elevation of the legs, regular walking, cool showers on the lower limbs, and medical compression — which the HAS recognizes as "the basic treatment for all chronic venous insufficiency"6, including during pregnancy where it is considered safe and appropriate. The prescription and choice of the appropriate compression is the responsibility of your doctor, physiotherapist or midwife.

This article is for information and educational purposes. It is not a substitute for medical advice. If you are unsure about your symptoms, consult a healthcare professional. This content does not mention or refer to any medical device product or brand.

  1. Written question No 26158. (n.d.). https://www.assemblee-nationale.fr/dyn/13/questions/QANR5L13QE26158
  2. Coverage of drugs subject to re-evaluation. (n.d.). High Authority for Health. https://www.has-sante.fr/jcms/c_456052/fr/prise-en-charge-des-medicaments-soumis-a-reevaluation
  3. Haute Autorité de Santé & SOCOPHARM Laboratory. (n.d.). Opinion of the Transparency Commission - FLEBOSMIL Gé 300 mg, FLEBOSMIL Gé 600 mg. https://www.has-sante.fr/upload/docs/application/pdf/ct032052.pdf
  4. TRANSPARENCY COMMITTEE. (2005). OPINION OF THE TRANSPARENCY COMMISSION - MEDIVEINE 300 mg, tablet. https://www.has-sante.fr/upload/docs/application/pdf/ct032244.pdf
  5. How to treat venous insufficiency? - VIDAL. (2023b, October 31). VIDAL. https://www.vidal.fr/maladies/coeur-circulation-veines/jambes-lourdes/traitements.html
  6. TRANSPARENCY COMMITTEE. (2005b). OPINION OF THE TRANSPARENCY COMMITTEE. https://www.has-sante.fr/upload/docs/application/pdf/ct032324.pdf
  7. https://agence-prd.ansm.sante.fr/php/ecodex/ research done on venotonics on the market on 16/06/2026

Related to the same topic